Globitair

Breast Cancer Canada and AstraZeneca Canada Advance Next-Generation Survivorship Research

Financial PostCanada

Announced at ESMO 2026: $200,000 in matched funding to advance the future of Canadian breast cancer survivorship. TORONTO — Breast Cancer Canada and AstraZeneca Canada are investing $200,000 in matched research funding to address critical gaps in breast cancer survivorship and improve care for Canadians living with and beyond the disease. Announced at Breast Cancer […]

Read the full story at Financial PostOpen in the live monitor

Related discussion groups

No group discusses this yet. Start a discussion group and attach this story.

More news about Canada